Table of Contents 1 Rifapentine (CAS 61379-65-5) Market Overview 1.1 Product Overview and Scope of Rifapentine (CAS 61379-65-5) 1.2 Rifapentine (CAS 61379-65-5) Segment by Type 1.2.1 Global Rifapentine (CAS 61379-65-5) Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 20 Capsules/Box 1.2.3 24 Capsules/Box 1.3 Rifapentine (CAS 61379-65-5) Segment by Application 1.3.1 Rifapentine (CAS 61379-65-5) Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global Rifapentine (CAS 61379-65-5) Market Size Estimates and Forecasts 1.4.1 Global Rifapentine (CAS 61379-65-5) Revenue 2015-2026 1.4.2 Global Rifapentine (CAS 61379-65-5) Sales 2015-2026 1.4.3 Rifapentine (CAS 61379-65-5) Market Size by Region: 2020 Versus 2026 2 Global Rifapentine (CAS 61379-65-5) Market Competition by Manufacturers 2.1 Global Rifapentine (CAS 61379-65-5) Sales Market Share by Manufacturers (2015-2020) 2.2 Global Rifapentine (CAS 61379-65-5) Revenue Share by Manufacturers (2015-2020) 2.3 Global Rifapentine (CAS 61379-65-5) Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Rifapentine (CAS 61379-65-5) Manufacturing Sites, Area Served, Product Type 2.5 Rifapentine (CAS 61379-65-5) Market Competitive Situation and Trends 2.5.1 Rifapentine (CAS 61379-65-5) Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Rifapentine (CAS 61379-65-5) Players (Opinion Leaders) 3 Rifapentine (CAS 61379-65-5) Retrospective Market Scenario by Region 3.1 Global Rifapentine (CAS 61379-65-5) Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Rifapentine (CAS 61379-65-5) Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Rifapentine (CAS 61379-65-5) Market Facts & Figures by Country 3.3.1 North America Rifapentine (CAS 61379-65-5) Sales by Country 3.3.2 North America Rifapentine (CAS 61379-65-5) Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Rifapentine (CAS 61379-65-5) Market Facts & Figures by Country 3.4.1 Europe Rifapentine (CAS 61379-65-5) Sales by Country 3.4.2 Europe Rifapentine (CAS 61379-65-5) Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Rifapentine (CAS 61379-65-5) Market Facts & Figures by Region 3.5.1 Asia Pacific Rifapentine (CAS 61379-65-5) Sales by Region 3.5.2 Asia Pacific Rifapentine (CAS 61379-65-5) Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Rifapentine (CAS 61379-65-5) Market Facts & Figures by Country 3.6.1 Latin America Rifapentine (CAS 61379-65-5) Sales by Country 3.6.2 Latin America Rifapentine (CAS 61379-65-5) Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Rifapentine (CAS 61379-65-5) Market Facts & Figures by Country 3.7.1 Middle East and Africa Rifapentine (CAS 61379-65-5) Sales by Country 3.7.2 Middle East and Africa Rifapentine (CAS 61379-65-5) Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Rifapentine (CAS 61379-65-5) Historic Market Analysis by Type 4.1 Global Rifapentine (CAS 61379-65-5) Sales Market Share by Type (2015-2020) 4.2 Global Rifapentine (CAS 61379-65-5) Revenue Market Share by Type (2015-2020) 4.3 Global Rifapentine (CAS 61379-65-5) Price Market Share by Type (2015-2020) 4.4 Global Rifapentine (CAS 61379-65-5) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Rifapentine (CAS 61379-65-5) Historic Market Analysis by Application 5.1 Global Rifapentine (CAS 61379-65-5) Sales Market Share by Application (2015-2020) 5.2 Global Rifapentine (CAS 61379-65-5) Revenue Market Share by Application (2015-2020) 5.3 Global Rifapentine (CAS 61379-65-5) Price by Application (2015-2020) 6 Company Profiles and Key Figures in Rifapentine (CAS 61379-65-5) Business 6.1 Sine Pharma 6.1.1 Corporation Information 6.1.2 Sine Pharma Description, Business Overview and Total Revenue 6.1.3 Sine Pharma Rifapentine (CAS 61379-65-5) Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Sine Pharma Products Offered 6.1.5 Sine Pharma Recent Development 6.2 Changzheng Pharma 6.2.1 Changzheng Pharma Rifapentine (CAS 61379-65-5) Production Sites and Area Served 6.2.2 Changzheng Pharma Description, Business Overview and Total Revenue 6.2.3 Changzheng Pharma Rifapentine (CAS 61379-65-5) Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Changzheng Pharma Products Offered 6.2.5 Changzheng Pharma Recent Development 6.3 MED-SHINE 6.3.1 MED-SHINE Rifapentine (CAS 61379-65-5) Production Sites and Area Served 6.3.2 MED-SHINE Description, Business Overview and Total Revenue 6.3.3 MED-SHINE Rifapentine (CAS 61379-65-5) Sales, Revenue and Gross Margin (2015-2020) 6.3.4 MED-SHINE Products Offered 6.3.5 MED-SHINE Recent Development 6.4 Foutune Pharma 6.4.1 Foutune Pharma Rifapentine (CAS 61379-65-5) Production Sites and Area Served 6.4.2 Foutune Pharma Description, Business Overview and Total Revenue 6.4.3 Foutune Pharma Rifapentine (CAS 61379-65-5) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Foutune Pharma Products Offered 6.4.5 Foutune Pharma Recent Development 6.5 Sanofi 6.5.1 Sanofi Rifapentine (CAS 61379-65-5) Production Sites and Area Served 6.5.2 Sanofi Description, Business Overview and Total Revenue 6.5.3 Sanofi Rifapentine (CAS 61379-65-5) Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Sanofi Products Offered 6.5.5 Sanofi Recent Development 7 Rifapentine (CAS 61379-65-5) Manufacturing Cost Analysis 7.1 Rifapentine (CAS 61379-65-5) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Rifapentine (CAS 61379-65-5) 7.4 Rifapentine (CAS 61379-65-5) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Rifapentine (CAS 61379-65-5) Distributors List 8.3 Rifapentine (CAS 61379-65-5) Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Rifapentine (CAS 61379-65-5) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Rifapentine (CAS 61379-65-5) by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Rifapentine (CAS 61379-65-5) by Type (2021-2026) 10.2 Rifapentine (CAS 61379-65-5) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Rifapentine (CAS 61379-65-5) by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Rifapentine (CAS 61379-65-5) by Application (2021-2026) 10.3 Rifapentine (CAS 61379-65-5) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Rifapentine (CAS 61379-65-5) by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Rifapentine (CAS 61379-65-5) by Region (2021-2026) 10.4 North America Rifapentine (CAS 61379-65-5) Estimates and Projections (2021-2026) 10.5 Europe Rifapentine (CAS 61379-65-5) Estimates and Projections (2021-2026) 10.6 Asia Pacific Rifapentine (CAS 61379-65-5) Estimates and Projections (2021-2026) 10.7 Latin America Rifapentine (CAS 61379-65-5) Estimates and Projections (2021-2026) 10.8 Middle East and Africa Rifapentine (CAS 61379-65-5) Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Rifapentine (CAS 61379-65-5) Sales (Kg) Growth Rate Comparison by Type (2015-2026) Table 2. Global Rifapentine (CAS 61379-65-5) Sales (Kg) Comparison by Application: 2020 VS 2026 Table 3. Global Rifapentine (CAS 61379-65-5) Market Size by Type (Kg) (US$ Million) (2020 VS 2026) Table 4. Global Key Rifapentine (CAS 61379-65-5) Manufacturers Covered in This Study Table 5. Global Rifapentine (CAS 61379-65-5) Sales (Kg) by Manufacturers (2015-2020) Table 6. Global Rifapentine (CAS 61379-65-5) Sales Share by Manufacturers (2015-2020) Table 7. Global Rifapentine (CAS 61379-65-5) Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Rifapentine (CAS 61379-65-5) Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Rifapentine (CAS 61379-65-5) Average Price (USD/Kg) of Key Manufacturers (2015-2020) Table 10. Manufacturers Rifapentine (CAS 61379-65-5) Sales Sites and Area Served Table 11. Manufacturers Rifapentine (CAS 61379-65-5) Product Types Table 12. Global Rifapentine (CAS 61379-65-5) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Rifapentine (CAS 61379-65-5) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rifapentine (CAS 61379-65-5) as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Rifapentine (CAS 61379-65-5) Players Table 16. Global Rifapentine (CAS 61379-65-5) Sales (Kg) by Region (2015-2020) Table 17. Global Rifapentine (CAS 61379-65-5) Sales Market Share by Region (2015-2020) Table 18. Global Rifapentine (CAS 61379-65-5) Revenue (Million US$) by Region (2015-2020) Table 19. Global Rifapentine (CAS 61379-65-5) Revenue Market Share by Region (2015-2020) Table 20. North America Rifapentine (CAS 61379-65-5) Sales by Country (2015-2020) (Kg) Table 21. North America Rifapentine (CAS 61379-65-5) Sales Market Share by Country (2015-2020) Table 22. North America Rifapentine (CAS 61379-65-5) Revenue by Country (2015-2020) (US$ Million) Table 23. North America Rifapentine (CAS 61379-65-5) Revenue Market Share by Country (2015-2020) Table 24. Europe Rifapentine (CAS 61379-65-5) Sales by Country (2015-2020) (Kg) Table 25. Europe Rifapentine (CAS 61379-65-5) Sales Market Share by Country (2015-2020) Table 26. Europe Rifapentine (CAS 61379-65-5) Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Rifapentine (CAS 61379-65-5) Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Rifapentine (CAS 61379-65-5) Sales by Region (2015-2020) (Kg) Table 29. Asia Pacific Rifapentine (CAS 61379-65-5) Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Rifapentine (CAS 61379-65-5) Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Rifapentine (CAS 61379-65-5) Revenue Market Share by Region (2015-2020) Table 32. Latin America Rifapentine (CAS 61379-65-5) Sales by Country (2015-2020) (Kg) Table 33. Latin America Rifapentine (CAS 61379-65-5) Sales Market Share by Country (2015-2020) Table 34. Latin America Rifapentine (CAS 61379-65-5) Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Rifapentine (CAS 61379-65-5) Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Rifapentine (CAS 61379-65-5) Sales by Country (2015-2020) (Kg) Table 37. Middle East and Africa Rifapentine (CAS 61379-65-5) Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Rifapentine (CAS 61379-65-5) Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Rifapentine (CAS 61379-65-5) Revenue Market Share by Country (2015-2020) Table 40. Global Rifapentine (CAS 61379-65-5) Sales (Kg) by Type (2015-2020) Table 41. Global Rifapentine (CAS 61379-65-5) Sales Share by Type (2015-2020) Table 42. Global Rifapentine (CAS 61379-65-5) Revenue (Million US$) by Type (2015-2020) Table 43. Global Rifapentine (CAS 61379-65-5) Revenue Share by Type (2015-2020) Table 44. Global Rifapentine (CAS 61379-65-5) Price (USD/Kg) by Type (2015-2020) Table 45. Global Rifapentine (CAS 61379-65-5) Sales (Kg) by Application (2015-2020) Table 46. Global Rifapentine (CAS 61379-65-5) Sales Market Share by Application (2015-2020) Table 47. Global Rifapentine (CAS 61379-65-5) Sales Growth Rate by Application (2015-2020) Table 48. Sine Pharma Rifapentine (CAS 61379-65-5) Corporation Information Table 49. Sine Pharma Description and Business Overview Table 50. Sine Pharma Rifapentine (CAS 61379-65-5) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 51. Sine Pharma Main Product Table 52. Sine Pharma Recent Development Table 53. Changzheng Pharma Rifapentine (CAS 61379-65-5) Corporation Information Table 54. Changzheng Pharma Corporation Information Table 55. Changzheng Pharma Rifapentine (CAS 61379-65-5) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 56. Changzheng Pharma Main Product Table 57. Changzheng Pharma Recent Development Table 58. MED-SHINE Rifapentine (CAS 61379-65-5) Corporation Information Table 59. MED-SHINE Corporation Information Table 60. MED-SHINE Rifapentine (CAS 61379-65-5) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 61. MED-SHINE Main Product Table 62. MED-SHINE Recent Development Table 63. Foutune Pharma Rifapentine (CAS 61379-65-5) Corporation Information Table 64. Foutune Pharma Corporation Information Table 65. Foutune Pharma Rifapentine (CAS 61379-65-5) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 66. Foutune Pharma Main Product Table 67. Foutune Pharma Recent Development Table 68. Sanofi Rifapentine (CAS 61379-65-5) Corporation Information Table 69. Sanofi Corporation Information Table 70. Sanofi Rifapentine (CAS 61379-65-5) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 71. Sanofi Main Product Table 72. Sanofi Recent Development Table 73. Sales Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Rifapentine (CAS 61379-65-5) Distributors List Table 76. Rifapentine (CAS 61379-65-5) Customers List Table 77. Market Key Trends Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 79. Key Challenges Table 80. Global Rifapentine (CAS 61379-65-5) Sales (Kg) Forecast by Type (2021-2026) Table 81. Global Rifapentine (CAS 61379-65-5) Sales Market Share Forecast by Type (2021-2026) Table 82. Global Rifapentine (CAS 61379-65-5) Revenue (Million US$) Forecast by Type (2021-2026) Table 83. Global Rifapentine (CAS 61379-65-5) Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 84. Global Rifapentine (CAS 61379-65-5) Sales (Kg) Forecast by Application (2021-2026) Table 85. Global Rifapentine (CAS 61379-65-5) Revenue (Million US$) Forecast by Application (2021-2026) Table 86. Global Rifapentine (CAS 61379-65-5) Sales (Kg) Forecast by Region (2021-2026) Table 87. Global Rifapentine (CAS 61379-65-5) Sales Market Share Forecast by Region (2021-2026) Table 88. Global Rifapentine (CAS 61379-65-5) Revenue Forecast by Region (2021-2026) (US$ Million) Table 89. Global Rifapentine (CAS 61379-65-5) Revenue Market Share Forecast by Region (2021-2026) Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Rifapentine (CAS 61379-65-5) Figure 2. Global Rifapentine (CAS 61379-65-5) Sales Market Share by Type: 2020 VS 2026 Figure 3. 20 Capsules/Box Product Picture Figure 4. 24 Capsules/Box Product Picture Figure 5. Global Rifapentine (CAS 61379-65-5) Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Pharmacies Figure 7. Retail Pharmacies Figure 8. Online Pharmacies Figure 9. Global Rifapentine (CAS 61379-65-5) Market Size 2015-2026 (US$ Million) Figure 10. Global Rifapentine (CAS 61379-65-5) Sales Capacity (Kg) (2015-2026) Figure 11. Global Rifapentine (CAS 61379-65-5) Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Rifapentine (CAS 61379-65-5) Sales Share by Manufacturers in 2020 Figure 13. Global Rifapentine (CAS 61379-65-5) Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Rifapentine (CAS 61379-65-5) Revenue in 2019 Figure 15. Rifapentine (CAS 61379-65-5) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Rifapentine (CAS 61379-65-5) Sales Market Share by Region (2015-2020) Figure 17. Global Rifapentine (CAS 61379-65-5) Sales Market Share by Region in 2019 Figure 18. Global Rifapentine (CAS 61379-65-5) Revenue Market Share by Region (2015-2020) Figure 19. Global Rifapentine (CAS 61379-65-5) Revenue Market Share by Region in 2019 Figure 20. North America Rifapentine (CAS 61379-65-5) Sales Market Share by Country in 2019 Figure 21. North America Rifapentine (CAS 61379-65-5) Revenue Market Share by Country in 2019 Figure 22. U.S. Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 23. U.S. Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 25. Canada Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Rifapentine (CAS 61379-65-5) Sales Market Share by Country in 2019 Figure 27. Europe Rifapentine (CAS 61379-65-5) Revenue Market Share by Country in 2019 Figure 28. Germany Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 29. Germany Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 31. France Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 33. U.K. Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 35. Italy Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 37. Russia Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Rifapentine (CAS 61379-65-5) Sales Market Share by Region in 2019 Figure 39. Asia Pacific Rifapentine (CAS 61379-65-5) Revenue Market Share by Region in 2019 Figure 40. China Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 41. China Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 43. Japan Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 45. South Korea Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 47. India Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 49. Australia Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 51. Taiwan Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 53. Indonesia Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 55. Thailand Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 57. Malaysia Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 59. Philippines Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 61. Vietnam Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Rifapentine (CAS 61379-65-5) Sales Market Share by Country in 2019 Figure 63. Latin America Rifapentine (CAS 61379-65-5) Revenue Market Share by Country in 2019 Figure 64. Mexico Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 65. Mexico Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 67. Brazil Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 69. Argentina Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Rifapentine (CAS 61379-65-5) Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Rifapentine (CAS 61379-65-5) Revenue Market Share by Country in 2019 Figure 72. Turkey Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 73. Turkey Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 75. Saudi Arabia Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Rifapentine (CAS 61379-65-5) Sales Growth Rate (2015-2020) (Kg) Figure 77. U.A.E Rifapentine (CAS 61379-65-5) Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Rifapentine (CAS 61379-65-5) by Type (2015-2020) Figure 79. Sales Market Share of Rifapentine (CAS 61379-65-5) by Type in 2019 Figure 80. Revenue Share of Rifapentine (CAS 61379-65-5) by Type (2015-2020) Figure 81. Revenue Market Share of Rifapentine (CAS 61379-65-5) by Type in 2019 Figure 82. Global Rifapentine (CAS 61379-65-5) Sales Growth by Type (2015-2020) (Kg) Figure 83. Global Rifapentine (CAS 61379-65-5) Sales Market Share by Application (2015-2020) Figure 84. Global Rifapentine (CAS 61379-65-5) Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Rifapentine (CAS 61379-65-5) by Application (2015-2020) Figure 86. Global Revenue Share of Rifapentine (CAS 61379-65-5) by Application in 2020 Figure 87. Sine Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Changzheng Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. MED-SHINE Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Foutune Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Price Trend of Key Raw Materials Figure 93. Manufacturing Cost Structure of Rifapentine (CAS 61379-65-5) Figure 94. Manufacturing Process Analysis of Rifapentine (CAS 61379-65-5) Figure 95. Rifapentine (CAS 61379-65-5) Industrial Chain Analysis Figure 96. Channels of Distribution Figure 97. Distributors Profiles Figure 98. Porter's Five Forces Analysis Figure 99. North America Rifapentine (CAS 61379-65-5) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 100. North America Rifapentine (CAS 61379-65-5) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 101. Europe Rifapentine (CAS 61379-65-5) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 102. Europe Rifapentine (CAS 61379-65-5) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Latin America Rifapentine (CAS 61379-65-5) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 104. Latin America Rifapentine (CAS 61379-65-5) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Middle East and Africa Rifapentine (CAS 61379-65-5) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 106. Middle East and Africa Rifapentine (CAS 61379-65-5) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Asia Pacific Rifapentine (CAS 61379-65-5) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 108. Asia Pacific Rifapentine (CAS 61379-65-5) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Sine Pharma Changzheng Pharma MED-SHINE Foutune Pharma Sanofi